Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases with an initial focus on severe respiratory conditions. The company is led by a highly experienced team of biopharmaceutical executives with deep discovery, development, and commercialization expertise. The company is advancing a potential best-in-class thymic stromal lymphopoietin (TSLP) monoclonal antibody into phase 2 development and creating novel, long-acting bispecific programs for immunological diseases.
Company Details
- Employees
- 25
- Address
- Aeschenplatz 6, Basel,bs 4052,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.windwardbio.com
- HQ
- Basel, BS
Windward Bio Questions
Windward Bio's website is https://www.windwardbio.com
Windward Bio's LinkedIn profile is https://ch.linkedin.com/company/windward-bio-001
Windward Bio has
25 employees.
View email and phone details for 25
employees at Windward Bio.
Windward Bio's industry is
Biotechnology Research
Windward Bio's top competitors are
Numab Therapeutics Ag,
Umoja Biopharma,
Normunity,
Light Horse Therapeutics,
Kardigan,
Tenvie Therapeutics,
Be Biopharma,
Tune Therapeutics,
Timberlyne Therapeutics,
Ouro Medicines.
Windward Bio's categories are Biotechnology Research
